On Monday, Vistagen Therapeutics Inc (NASDAQ: VTGN) opened lower -3.83% from the last session, before settling in for the closing price of $0.78. Price fluctuations for VTGN have ranged from $0.68 to $5.14 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 35.63% over the last five years. Company’s average yearly earnings per share was noted -12.34% at the time writing. With a float of $33.66 million, this company’s outstanding shares have now reached $38.89 million.
Vistagen Therapeutics Inc (VTGN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vistagen Therapeutics Inc is 14.78%, while institutional ownership is 44.98%.
Vistagen Therapeutics Inc (VTGN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.46 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.52) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.57% during the next five years compared to 35.63% growth over the previous five years of trading.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Trading Performance Indicators
Check out the current performance indicators for Vistagen Therapeutics Inc (VTGN). In the past quarter, the stock posted a quick ratio of 5.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 42.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Vistagen Therapeutics Inc (VTGN)
Analysing the last 5-days average volume posted by the [Vistagen Therapeutics Inc, VTGN], we can find that recorded value of 19.81 million was better than the volume posted last year of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 1.58%.
During the past 100 days, Vistagen Therapeutics Inc’s (VTGN) raw stochastic average was set at 1.63%, which indicates a significant decrease from 1.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3226 in the past 14 days, which was higher than the 0.2904 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.9219, while its 200-day Moving Average is $3.0124. Now, the first resistance to watch is $0.8085. This is followed by the second major resistance level at $0.8691. The third major resistance level sits at $0.8993. If the price goes on to break the first support level at $0.7177, it is likely to go to the next support level at $0.6875. Now, if the price goes above the second support level, the third support stands at $0.6269.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Key Stats
There are currently 39,495K shares outstanding in the company with a market cap of 29.54 million. Presently, the company’s annual sales total 490 K according to its annual income of -51,420 K. Last quarter, the company’s sales amounted to 260 K and its income totaled -19,420 K.
